Replies to post #71 on Virax Biolabs Group Ltd (VRAX)

[James salmon]

Did you notice this from filing just out;

“In addition, warrants to purchase up to an aggregate of 3,495,000 Ordinary Shares which were previously issued to the purchaser in a private placement consummated by the Company in November 2022 and have an exercise price of $1.73 per share were cancelled simultaneously with the closing of this Offering.”